|
Special
Features, Awards Presentations, and Meeting Highlights
Table
of Contents
HOSPITAL
TOURS
Are
you interested in touring Cleveland's childrens hospitals? Tours
of Rainbow Babies and Children's Hospital and Cleveland Clinic Children's
Hospital on Thursday, September 24 at 9:00 am. Registration price
is $25.00 and includes transportation. Seats are limited.
You
can sign-up when you register for the conference. If you have already
registered, please email Julie Clyce at julie.clyce@ppag.org for
more information.
Keynote
Speaker
Michael
Anderson, MD is our keynote speaker for the 18th Pediatric Pharmacy
Conference.
Dr. Anderson is Vice President and Associate Chief Medical Officer
at University Hospitals and Associate Professor of Pediatrics at
the Case Western Reserve School of Medicine in Cleveland, Ohio.
He is also a pediatric critical care specialist at Rainbow Babies
& Children’s Hospital.
In
his role as Associate Chief Medical Officer at UH, Dr Anderson is
charged with oversight of quality, risk management, credentialing
and medical staff offices. He also assists the CMO in the daily
operations of the nine-hospital UH system.
As
a pediatric specialist, Dr. Anderson has been active at the local,
state and national level in pediatric disaster readiness and response.
Currently, Dr Anderson is pooling the talent of Ohio’s six
children’s hospitals to form a disaster response team to serve
as a state and federal asset in the wake of future disasters. Through
key partnerships at the state and federal levels, including the
Ohio Children’s Hospital Association, the Ohio Hospital Association,
the National Association of Children’s Hospitals and the American
Academy of Pediatrics, Dr. Anderson is working to ensure that children’s
needs are at the forefront of disaster medicine and create a disaster
response team capable of caring for children during these times.
In addition to disaster preparedness and response, Dr. Anderson’s
research and clinical interests include national physician workforce,
pediatric critical care transport and national health policy issues
for children. He has been awarded grant funding from the National
Institutes of Health (NIH) and the Emergency Medical Systems for
Children (EMS-C). He has published on a variety of pediatric critical
care topics including sepsis, acute respiratory distress syndrome
(ARDS), care of the immunosupressed patient, and transport of the
unstable pediatric patient. Dr Anderson has brought his expertise
to three national committees for the AAP and served as the chair
of the Committee on Pediatric Workforce from 2004 to 2006. In 2003,
Dr. Anderson was appointed by the AAP to the United States Department
of Health and Human Services/Maternal and Child Health Bureau (MCHB)
expert panel on pediatric subspecialty workforce.
Super
Sessions
Adolescent
Issues
September 25, 2009 3:45-5:15 pm
Hot
Topics in Pediatric Pharmacy
September 27, 2009 9:40-11:40 am
Sumner
J. Yaffe Award
 Stephen
Paul Spielberg, MD has been named as the 2009 recipient of the Sumner
J. Yaffe Lifetime Achivement Award in Pediatric Pharmacology and
Therapeutics.
Dr. Spielberg is Director of the Center for Personalized Medicine
and Therapeutic Innovation, Marion Merrell Dow Chair in Pediatric
Pharmacogenomics at Children's Mercy Hospital and Clinics in Kansas
City, MO. He is also Professor at University of Missouri-Kansas
City School of Medicine.
Prior
to joining Mercy, Dr. Spielberg served as Dean of Dartmouth Medical
School and vice president for health affairs for Dartmouth College.
A leader in medical teaching and research and a children's health
advocate nationally and internationally, he is also professor of
pediatrics and of pharmacology and toxicology. Before joining Dartmouth,
effective July 1, 2003, he was vice president for pediatric drug
development at Johnson & Johnson Pharmaceutical Research and
Development in Titusville, NJ. Over the previous 20 years he held
positions at the Johns Hopkins University School of Medicine, the
University of Toronto and its Hospital for Sick Children, and Merck
Research Laboratories. Spielberg, whose research interests include
mechanisms of idiosyncratic adverse drug reactions and genetic differences
in susceptibility (human pharmacogenetics), has championed the needs
of ill children in clinical pharmacology and clinical trials. At
Johnson & Johnson, he and his department successfully developed
new knowledge for labeling medicines for safe and effective pediatric
use and helped advance new approaches to clinical investigation
in children. He led efforts in Congress in behalf of the Best Pharmaceuticals
for Children Act, which passed and was signed into law in 2002.
Also, he has promoted pediatric investigation of new medicines,
international harmonization of drug development regulations for
children, and the highest ethical standards in pediatric investigative
programs.
His work in this area was recognized by the William B. Abrams Award
and Lectureship from the US Food and Drug Administration (FDA) and
the American Society of Clinical Pharmacology and Therapeutics,
and by the Board of Directors Exceptional Service Award from Pharmaceutical
Research and Manufacturers of America. Other honors include the
Rawls-Palmer Award from the American Society for Clinical Pharmacology
and Therapeutics the first Werner Kalow Award for Pharmacogenetics
and Drug Safety.
Dr. Spielberg will receive the Yaffe Award and give the annual Yaffe
Lecture at the 18th Pediatric Pharmacy Conference at the Renaissance
Cleveland Hotel on September 25, 2009.
Previous
Yaffe Award Recipients are:
2002: Sumner Yaffe, MD
2003: Miles Weiberger, MD
2004: William Evans, PharmD
2005: George McCracken, MD
2006: Cheston Berlin, MD
2007: Leslie Hendeles, PharmD
2008: Gregory Kearns, PharmD, PhD
Richard
A. Helms Award
 The
Pediatric Pharmacy Advocacy Group is pleased to announce Milap Nahata,
MS, PharmD, is the 2009 recipient of the Richard A. Helms Award
of Excellence in Pediatric Pharmacy Practice. The Helms Award recognizes
(1) sustained and meritorious contributions to PPAG and to pediatric
pharmacy practice, and (2) contributions of importance to education,
new knowledge, and outreach.
Dr.
Nahata is Professor and Chairman of the Department of Pharmacy Practice
at the Ohio State University. He is also Professor of Pediatrics
and Associate Director of Pharmacy at the OSU Medical Center. Dr.
Nahata received a Bachelors of Science in Pharmacy in 1973 from
the University of Bombay, a Masters of Science in Pharmaceutics
in 1975, and a Doctor of Pharmacy in 1977 from Duquesne University.
Dr.
Nahata has made outstanding contributions to the profession over
the course of his career. He has previously been recognized with
four national research achievement awards, two national distinguished
educator awards, and election to Fellow status by five professional
and scientific societies. Professor Nahata has received five teaching
awards from the College of Pharmacy and one teaching award from
The Ohio State University. He has served as president of two national
pharmacy organizations: American Association of Colleges of Pharmacy
and American College of Clinical Pharmacy. He is also a member of
the Pediatric Pharmacy Advocacy Group and a member of the Editorial
Board of the Journal of Pediatric Pharmacology and Therapeutics.
Most recently, Dr. Nahata was inducted into the Institutes of Medicine.
The Helms Award will be presented at the 18th Pediatric Pharmacy
Conference in Cleveland, Ohio on September 26, 2009.
Previous
Helms Award Recipients are:
2006: Richard Helms, PharmD
2007: Robert Poole, PharmD
2008: Peter Gal, PharmD
Clinical
Pearls
There
will be two Clinical Pearl Session at the Annual meeting this year.
The first session on Extreme Dosing will be on Saturday, September
25, 2009. The second session on Narcotics, Sedation, etc. will be
held on Sunday, September 26, 2009. Breakfast will be served during
the Clinical Pearl Sessions.
New
Practitioners Luncheon
Continuing
a new tradition at PPAG, a lunch seminar will be provided for interested
residents, fellows, and new practitioners (out of residency 2-3
years). This year a panel will discuss leadership and how to seek
a mentor for your career. This lunch is free to attend, but you
MUST sign-up in advance to attend. You will be able to sign-up during
the registration process. Seating is limited.
Poster
Presentation Information
There
will be two concurrent poster sessions: Scientific-based Poster
Session and Practice-based Poster Session.
Scientific
Poster Session
Research
abstracts presented at PPAG report the results of a scientific investigation
or a clinical observation (case report) involving some aspect of
pharmacotherapy. Scientific investigations can be either clinical,
basic, or translational and are either hypothesis-driven or descriptive
in nature. To be accepted for presentation, research abstracts must
have either preliminary or final results. The abstract may be submitted
in any of the following categories: Scientific, Case Report, and
Encore Presentations (a poster that has been presented and published
elsewhere. The original citation must accompany encore presentations).
From
these posters, the Research Committee will choose two awards; the
Best Original Paper, and the Young Investigator Award.
Practice
Poster Session
Best
and Innovative Pediatric Pharmacy Practice Abstracts typically describe
programs, systems, or projects that are innovative, creative, cost-effective,
and improve practice in pediatric pharmacy. BPA/IPPP Posters will
be selected based on achievement of excellence in each of the four
areas.
From
these abstracts, the Advocacy Committee will reward two Best Practice
Awards. The Awardees will present their work at the Annual Meeting.
|
